Literature DB >> 30885846

Heart-Kidney and Heart-Liver Transplantation Provide Immunoprotection to the Cardiac Allograft.

Alan S Chou1, Andreas Habertheuer1, Amanda L Chin1, Ibrahim Sultan2, Prashanth Vallabhajosyula3.   

Abstract

BACKGROUND: Prior single-center studies suggest that kidney and liver allografts are immunoprotective toward transplanted hearts. The broader effects of the simultaneous transplantation of kidney or liver on protection from rejection are unclear.
METHODS: The United Network for Organ Sharing database for heart transplantation was queried from 1987 to 2015 and stratified into patients undergoing heart-liver transplantation (HLT) (n = 192), heart-kidney transplantation (HKT) (n = 1,174), and heart-only transplantation (HT) (n = 61,471). Perioperative and follow-up data were compared between HT versus HLT and HT versus HKT groups using analysis of variance (continuous), chi-square test (categorical), and Kaplan-Meier curves (survival).
RESULTS: HKT patients were older (51.2 ± 13.4 years of age) compared with HT patients (45.6 ± 19.2 years of age; p < 0.0001), with higher rate of diabetes (33.8% versus 14.8%; p < 0.0001) and dialysis (49.7% versus 2.1%; p < 0.0001). HKT (46.2%) and HLT (49.5%) patients had more urgent need for transplantation (status 1A) compared with HT patients (32%; p < 0.0001). Acute rejection episodes before discharge were lower in the HLT group (7.1% versus 3.1%; p = 0.03). Ten-year patient survivals were similar for HT (53.6%) versus HKT (56.7%) (p = 0.13) versus HLT (60.4%) (p = 0.09). Treatment for rejection during the first posttransplant year was lower in HLT (2.1%) and HKT (8.4%) compared with HT (17.4%) (p < 0.0001 for both). Cox multivariate analysis showed that cardiac allograft survival was improved in HKT (odds ratio, 0.58; 95% confidence interval [CI], 0.49 to 0.70; p < 0.0001). Additionally, HKT (hazard ratio, 0.52; 95% CI, 0.45 to 0.60; p < 0.0001) and HLT (hazard ratio, 0.24; 95% CI, 0.15 to 0.39; p < 0.0001) were associated with improved freedom from rejection.
CONCLUSIONS: Nationally, HKT and HLT have equivalent postoperative outcomes as HT. Simultaneous kidney or liver transplantation confers an improved clinical and immunologic outcome.
Copyright © 2019 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 30885846     DOI: 10.1016/j.athoracsur.2019.02.012

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  7 in total

1.  Optimal patient selection for simultaneous heart-kidney transplant: A modified cost-effectiveness analysis.

Authors:  Brian Wayda; Xingxing S Cheng; Jeremy D Goldhaber-Fiebert; Kiran K Khush
Journal:  Am J Transplant       Date:  2021-11-30       Impact factor: 8.086

2.  Comparison of combined heart‒liver vs heart-only transplantation in pediatric and young adult Fontan recipients.

Authors:  Danielle Sganga; Seth A Hollander; Sumeet Vaikunth; Christiane Haeffele; Rachel Bensen; Manchula Navaratnam; Nancy McDonald; Elizabeth Profita; Katsuhide Maeda; Waldo Concepcion; Daniel Bernstein; Sharon Chen
Journal:  J Heart Lung Transplant       Date:  2020-12-29       Impact factor: 10.247

3.  Need for improvements in simultaneous heart-kidney allocation: The limitation of pretransplant glomerular filtration rate.

Authors:  Brian I Shaw; Mariya L Samoylova; Scott Sanoff; Andrew S Barbas; Debra L Sudan; L Ebony Boulware; Lisa M McElroy
Journal:  Am J Transplant       Date:  2021-02-09       Impact factor: 9.369

4.  Heart-kidney listing is better than isolated heart listing for pediatric heart transplant candidates with significant renal insufficiency.

Authors:  Alia Dani; Nina Price; Karthik Thangappan; Thomas D Ryan; David K Hooper; David S Cooper; David G Lehenbauer; Clifford Chin; Farhan Zafar; David L S Morales
Journal:  J Thorac Cardiovasc Surg       Date:  2022-03-01       Impact factor: 6.439

Review 5.  Congestive Hepatopathy.

Authors:  José Ignacio Fortea; Ángela Puente; Antonio Cuadrado; Patricia Huelin; Raúl Pellón; Francisco José González Sánchez; Marta Mayorga; María Luisa Cagigal; Inés García Carrera; Marina Cobreros; Javier Crespo; Emilio Fábrega
Journal:  Int J Mol Sci       Date:  2020-12-10       Impact factor: 5.923

6.  Cardiac Outcomes in Isolated Heart and Simultaneous Kidney and Heart Transplants in the United States.

Authors:  Krishna Adit Agarwal; Het Patel; Nikhil Agrawal; Francesca Cardarelli; Nitender Goyal
Journal:  Kidney Int Rep       Date:  2021-07-14

Review 7.  Combined Heart-Kidney Transplantation: Indications, Outcomes, and Controversies.

Authors:  Syed Adeel Ahsan; Ashrith Guha; Juan Gonzalez; Arvind Bhimaraj
Journal:  Methodist Debakey Cardiovasc J       Date:  2022-09-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.